| 000 | 01649 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515171450.0 | ||
| 264 | 0 | _c20090702 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/sj.bjc.6605081 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEklund, C M | |
| 245 | 0 | 0 |
_aC-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cJun 2009 |
||
| 300 |
_a1846-51 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aBone Neoplasms _xblood |
| 650 | 0 | 4 |
_aC-Reactive Protein _xgenetics |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aGenome-Wide Association Study |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHaplotypes _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aTammela, T L J | |
| 700 | 1 | _aSchleutker, J | |
| 700 | 1 | _aHurme, M | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 100 _gno. 12 _gp. 1846-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6605081 _zAvailable from publisher's website |
| 999 |
_c18864045 _d18864045 |
||